ArticleBMC plant biology2025
Transcriptomic analysis offers deep insights into the Increased Grain Length 1 (IGL1) regulation of grain length.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Correction: Transcriptomic analysis Ofers deep insights into the increased grain length 1 (IGL1) regulation of grain length.BMC plant biology · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
15 authors.
Funding
Abstract
backgroundAlthough great progress has been made in recent years in identifying novel genes or natural alleles for rice yield improvement, the molecular mechanisms of how these genes/natural alleles regulate yield-associated traits, such as grain length and 1000-grain weight, remain largely unclear. An in-depth understanding of the roles of these genes/natural alleles in controlling yield traits become a necessity to ultimately increase rice yield via novel molecular techniques, such as gene editing.
resultsIn this study, the roles of IGL1, which was previously identified through a map-based cloning approach, in the regulation of grain length were investigated by overexpressing and knocking out it in the Nipponbare genetic background. Overexpression and knockout of IGL1 (the resulting transgenic lines were hereafter designated IGL1-OE and IGL1-CR lines, respectively) led to elongation and shortening of grains, respectively. To further elucidate the molecular mechanisms behind the IGL1 action, young panicles from IGL1-OE and IGL1-CR lines were subjected to mRNA sequencing. The results showed that both overexpression and knockout of IGL1 all resulted in a large number of upregulated and downregulated differentially expression genes (DEGs) relative to wild-type NPB control lines. A total of 984 DEGs overlapped between upregulated DEGs from IGL1-OE and downregulated DEGs from IGL1-CR; 1146 DEGs were common to downregulated DEGs from IGL1-OE and upregulated DEGs from IGL1-CR. GO term and KEGG pathway analysis revealed that IGL1-upregulated DEGs were associated with extracellular region, protein ubiquitination, cell-wall modification, BR signaling, cell cycle, etc.; by comparison, the IGL1-downregulated DEGs were connected with extracellular region, response to wounding, flavonoid biosynthesis, jasmonic-acid signaling, glucose/sucrose metabolism, etc. Some phytohormone-associated genes (like OsYUCCA4, OsPIN10b, OsBAK1, and OsDLT), TF genes (like OsMADS1 and OsGASR9), grain length-regulating genes (like An-1, GS9, OsIQD14, and TGW2) showed significant upregulation or downregulation in IGL1-OE or IGL1-CR.
conclusionOur result clearly demonstrated that IGL1 is an important regulator of grain length, and has profound impacts on genome-wide gene expression, suggesting that it may work together with certain TFs. Overexpression or knockout of IGL1 appears to cause complex expression changes of genes associated with phytohormones, TFs, grain length-regulating factors, which ultimately brings about the grain elongation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.